vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Weave Communications, Inc. (WEAV). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $63.4M, roughly 1.2× Weave Communications, Inc.). On growth, Weave Communications, Inc. posted the faster year-over-year revenue change (17.0% vs -36.9%). Weave Communications, Inc. produced more free cash flow last quarter ($5.1M vs $-6.6M). Over the past eight quarters, Weave Communications, Inc.'s revenue compounded faster (15.9% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Weave Communications, Inc. develops integrated all-in-one customer engagement and communication platforms tailored for small and medium-sized businesses. Its product suite includes cloud-based phone systems, appointment scheduling, payment processing, review management and text messaging tools, primarily serving local service sectors like dental clinics, healthcare practices and fitness studios across the U.S. and Canada.

MED vs WEAV — Head-to-Head

Bigger by revenue
MED
MED
1.2× larger
MED
$75.1M
$63.4M
WEAV
Growing faster (revenue YoY)
WEAV
WEAV
+53.9% gap
WEAV
17.0%
-36.9%
MED
More free cash flow
WEAV
WEAV
$11.8M more FCF
WEAV
$5.1M
$-6.6M
MED
Faster 2-yr revenue CAGR
WEAV
WEAV
Annualised
WEAV
15.9%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
WEAV
WEAV
Revenue
$75.1M
$63.4M
Net Profit
$-1.8M
Gross Margin
69.4%
72.7%
Operating Margin
-10.4%
-3.4%
Net Margin
-2.9%
Revenue YoY
-36.9%
17.0%
Net Profit YoY
72.5%
EPS (diluted)
$-1.64
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
WEAV
WEAV
Q4 25
$75.1M
$63.4M
Q3 25
$89.4M
$61.3M
Q2 25
$105.6M
$58.5M
Q1 25
$115.7M
$55.8M
Q4 24
$119.0M
$54.2M
Q3 24
$140.2M
$52.4M
Q2 24
$168.6M
$50.6M
Q1 24
$174.7M
$47.2M
Net Profit
MED
MED
WEAV
WEAV
Q4 25
$-1.8M
Q3 25
$-2.3M
$-8.7M
Q2 25
$2.5M
$-8.7M
Q1 25
$-772.0K
$-8.8M
Q4 24
$-6.7M
Q3 24
$1.1M
$-5.9M
Q2 24
$-8.2M
$-8.6M
Q1 24
$8.3M
$-7.2M
Gross Margin
MED
MED
WEAV
WEAV
Q4 25
69.4%
72.7%
Q3 25
69.5%
72.3%
Q2 25
72.6%
71.7%
Q1 25
72.8%
71.6%
Q4 24
74.1%
72.1%
Q3 24
75.4%
72.0%
Q2 24
73.2%
71.4%
Q1 24
72.8%
69.9%
Operating Margin
MED
MED
WEAV
WEAV
Q4 25
-10.4%
-3.4%
Q3 25
-4.6%
-14.6%
Q2 25
-1.0%
-17.4%
Q1 25
-1.1%
-16.7%
Q4 24
0.6%
-13.6%
Q3 24
1.5%
-12.7%
Q2 24
-4.7%
-18.3%
Q1 24
4.5%
-17.3%
Net Margin
MED
MED
WEAV
WEAV
Q4 25
-2.9%
Q3 25
-2.5%
-14.1%
Q2 25
2.3%
-14.9%
Q1 25
-0.7%
-15.8%
Q4 24
-12.4%
Q3 24
0.8%
-11.2%
Q2 24
-4.8%
-16.9%
Q1 24
4.8%
-15.3%
EPS (diluted)
MED
MED
WEAV
WEAV
Q4 25
$-1.64
$-0.03
Q3 25
$-0.21
$-0.11
Q2 25
$0.22
$-0.11
Q1 25
$-0.07
$-0.12
Q4 24
$0.08
$-0.10
Q3 24
$0.10
$-0.08
Q2 24
$-0.75
$-0.12
Q1 24
$0.76
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
WEAV
WEAV
Cash + ST InvestmentsLiquidity on hand
$167.3M
$55.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$82.4M
Total Assets
$248.0M
$208.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
WEAV
WEAV
Q4 25
$167.3M
$55.0M
Q3 25
$173.5M
$64.4M
Q2 25
$162.7M
$44.7M
Q1 25
$164.6M
$53.4M
Q4 24
$162.3M
$51.6M
Q3 24
$170.0M
$51.1M
Q2 24
$163.5M
$51.7M
Q1 24
$156.4M
$30.6M
Stockholders' Equity
MED
MED
WEAV
WEAV
Q4 25
$198.9M
$82.4M
Q3 25
$214.7M
$78.6M
Q2 25
$216.0M
$78.9M
Q1 25
$211.0M
$68.6M
Q4 24
$210.1M
$67.0M
Q3 24
$207.3M
$68.8M
Q2 24
$205.3M
$69.8M
Q1 24
$211.0M
$73.4M
Total Assets
MED
MED
WEAV
WEAV
Q4 25
$248.0M
$208.0M
Q3 25
$268.2M
$206.5M
Q2 25
$269.3M
$204.3M
Q1 25
$280.0M
$188.3M
Q4 24
$284.2M
$188.9M
Q3 24
$291.2M
$192.0M
Q2 24
$293.5M
$191.2M
Q1 24
$302.8M
$190.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
WEAV
WEAV
Operating Cash FlowLast quarter
$-5.3M
$6.2M
Free Cash FlowOCF − Capex
$-6.6M
$5.1M
FCF MarginFCF / Revenue
-8.8%
8.1%
Capex IntensityCapex / Revenue
1.8%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$15.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
WEAV
WEAV
Q4 25
$-5.3M
$6.2M
Q3 25
$12.1M
$6.1M
Q2 25
$-3.4M
$5.4M
Q1 25
$3.4M
$-219.0K
Q4 24
$-4.9M
$6.7M
Q3 24
$9.1M
$4.5M
Q2 24
$13.1M
$22.7M
Q1 24
$7.3M
$-19.7M
Free Cash Flow
MED
MED
WEAV
WEAV
Q4 25
$-6.6M
$5.1M
Q3 25
$10.8M
$5.8M
Q2 25
$-4.8M
$4.9M
Q1 25
$1.9M
$-663.0K
Q4 24
$-7.2M
$6.3M
Q3 24
$7.7M
$4.0M
Q2 24
$11.1M
$21.9M
Q1 24
$5.4M
$-20.2M
FCF Margin
MED
MED
WEAV
WEAV
Q4 25
-8.8%
8.1%
Q3 25
12.0%
9.4%
Q2 25
-4.5%
8.4%
Q1 25
1.6%
-1.2%
Q4 24
-6.1%
11.6%
Q3 24
5.5%
7.5%
Q2 24
6.6%
43.4%
Q1 24
3.1%
-42.9%
Capex Intensity
MED
MED
WEAV
WEAV
Q4 25
1.8%
1.8%
Q3 25
1.5%
0.5%
Q2 25
1.3%
0.9%
Q1 25
1.3%
0.8%
Q4 24
1.9%
0.7%
Q3 24
1.0%
1.0%
Q2 24
1.1%
1.5%
Q1 24
1.1%
1.1%
Cash Conversion
MED
MED
WEAV
WEAV
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons